Governance

Corporate governance model

Corporate governance model

Board of Directors

Chairman: Noriyuki Komuro

Directors:

  • Riccardo Palmisano, CEO
  • Laura Iris Ferro, independent
  • Sabina Grossi
  • David Kauffmann
  • Mario Masciocchi, independent
  • Patricio Massera
  • Tomoko Miyagawa
  • Raffaella Ruggiero, independent

Save for as indicated below, the Board of Directors, appointed by the Shareholders' Meeting of 30 April 2019, will remain in office for the three-year period 2019-2021. Directors Noriyuki Komuro, Patricio Massera, David Kauffmann and Tomoko Miyagawa were appointed by co-optation by the board of directors that met on 31 July 2020, following the resignation of Carlo Incerti, Alberto Luigi Carletti, Alfredo Messina and Elizabeth Robinson, and will remain in office until the next meeting, the date of which has not yet been established.

Committee for control & risks

Chairman: Mario Masciocchi, independent

Members:

  • Sabina Grossi
  • Laura Iris Ferro, independent

Remuneration and nomination committee

Chairman: Raffaella Ruggiero, independent

Members:

  • Laura Iris Ferro, independent
  • Sabina Grossi

Committee for transactions with related parties (COPC*)

Chairman: Mario Masciocchi, independent

Members:

  • Sabina Grossi
  • Laura Iris Ferro, independent

(*) By Board resolution of 11 November 2010, the function of the Committee is permanently assigned to the Committee for control & risks

Board of statutory auditors

Chairman: Riccardo Perotta

Auditors:

  • Alessia Bastiani
  • Michele Milano

Deputy Auditors:

  • Giuliana Maria Converti
  • Tommaso Casale

Save for as indicated below, the Board of Statutory Auditors, appointed by the Shareholders 'Meeting of April 30, 2019, will remain in office until the date of the Shareholders' Meeting called to approve the financial statements as of December 31, 2021. The auditor Alessia Bastiani succeeded Flavia Daunia Minutillo following her resignation on 25 June 2020 and will remain in office until the next meeting, whose date has not yet been established.

Supervisory body

Chairman: Ezio Simonelli

Members:
Giuseppe Garzillo
Alessandro Rossini

Data Protection Officer (DPO)

The Company has appointed a Data Protection Officer that can be contacted by e-mail at dpo@molmed.com

Scientific Advisory Board

Malcolm K. Brenner
Director of the Center for Cell and Gene Therapy and Professor of Medicine and of Pediatrics at Baylor
College of Medicine, Houston

Claudio Bordignon
MolMed Founder, SAB Chairman. Member of the Scientific Council of the European Research Council
Full Professor of hematology at the University San Raffaele in Milan

Malcolm K. Brenner
Director of the Center for Cell and Gene Therapy and Professor of Medicine and of Pediatrics at Baylor
College of Medicine, Houston, TX

Miguel-Angel Perales
Deputy Chief, Adult Bone Marrow Transplant Service at Memorial Sloan Kettering Cancer Center, NY, USA

Mohamad Mohty
Professor of Hematology and Head of the Hematology and cellular therapy Department at the Saint-
Antoine Hospital and University Pierre & Marie Curie, Paris

Gianpietro Dotti
Member of the UNC Lineberger Comprehensive Cancer Center and Professor of the Microbiology
and Immunology Director of the UNC Immunotherapy Program at the Univ. of North Carolina, NC

Società di revisione

 Reconta Ernst & Young S.p.A.